Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
8
15
2
0
ESPERION THERAPEUTICSCS INC Share · US29664W1053 · ESPR · A1W1SJ (XNMS) United States · Healthcare — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ESPERION THERAPEUTICSCS INC
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 100,00 %
Shares Float 207,91 M
Shares Outstanding 207,91 M
Invested Funds
The following funds have invested in ESPERION THERAPEUTICSCS INC:
Fund | Vol. in million 1.050,88 | Percentage (%) 2,35 % |
Fund | Vol. in million 5.807,04 | Percentage (%) 2,16 % |
Fund | Vol. in million 268,33 | Percentage (%) 1,51 % |
Fund | Vol. in million 338,89 | Percentage (%) 1,27 % |
Fund | Vol. in million 1.740,17 | Percentage (%) 0,14 % |
Company Profile for ESPERION THERAPEUTICSCS INC Share
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Company Data
Name ESPERION THERAPEUTICSCS INC
Company Esperion Therapeutics, Inc.
Symbol ESPR
Website
https://www.esperion.com
Primary Exchange 
NASDAQ/NMS (GLOBAL MARKET)
NASDAQ/NMS (GLOBAL MARKET)
WKN A1W1SJ
ISIN US29664W1053
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Sheldon L. Koenig
Market Capitalization 707 Mio
Country United States
Currency USD
Employees 0,3 T
Address 3891 Ranchero Drive, 48108 Ann Arbor
IPO Date 2018-01-29
Key Ratios
Dividend
Dividend Yield 99,37 %
Dividend per Share 3,16 USD
Payout Ratio —
Valuation
P/E Ratio -131,40x
P/B Ratio -2,60x
P/S Ratio 1,58x
P/FCF Ratio -36,35x
Margins
Gross Margin 65,00 %
Operating Margin 18,12 %
Net Margin -1,77 %
As of 17.08.2026
Dividends from 'ESPERION THERAPEUTICSCS INC'
| Ex-Date | Dividend per Share |
|---|---|
| 13.07.2026 | 3,16 USD |
Stock Splits
| Date | Split |
|---|---|
| 11.06.2013 | 1:7 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Düsseldorf | ETINRS53.DUSB |
| Frankfurt | 0ET.F |
| London | 0IIM.L |
| NASDAQ | ESPR |
| Quotrix | ETINRS53.DUSD |
More Shares
Investors who hold ESPERION THERAPEUTICSCS INC also have the following shares in their portfolio:
